Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
23.46
+0.75 (3.30%)
At close: Nov 4, 2024, 4:00 PM
23.64
+0.18 (0.77%)
After-hours: Nov 4, 2024, 4:00 PM EST
Bicycle Therapeutics Employees
Bicycle Therapeutics had 284 employees as of December 31, 2023. The number of employees increased by 48 or 20.34% compared to the previous year.
Employees
284
Change (1Y)
48
Growth (1Y)
20.34%
Revenue / Employee
$129,923
Profits / Employee
-$585,479
Market Cap
1.62B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Fortrea Holdings | 18,000 |
Teladoc Health | 5,600 |
Novavax | 1,543 |
Intellia Therapeutics | 526 |
Immunocore Holdings | 497 |
Dynavax Technologies | 408 |
Harrow | 315 |
Rocket Pharmaceuticals | 268 |
BCYC News
- 3 days ago - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 days ago - Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results - Business Wire
- 12 days ago - Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals - Business Wire
- 19 days ago - Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress - Business Wire
- 7 weeks ago - Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024 - Business Wire
- 2 months ago - Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone - Benzinga
- 2 months ago - Bicycle Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Bicycle Therapeutics Is Looking Increasingly Attractive - Seeking Alpha